The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Roux-en-Y Gastric Bypass Versus Adjustable Gastric Banding to Reduce Nonalcoholic Fatty Liver Disease: A 5-Year Controlled Longitudinal Study
Abstract
In Brief Objectives: To compare the long-term benefit of gastric bypass [Roux-en-Y gastric bypass (RYGB)] versus adjustable gastric banding (AGB) on nonalcoholic fatty liver disease (NAFLD) in severely obese patients. Background: NAFLD improves after weight loss surgery, but no histological study has compared the effects of the various bariatric interventions. Methods: Participants consisted of 1236 obese patients (body mass index = 48.4 ± 7.6 kg/m2), enrolled in a prospective longitudinal study for up to 5 years after RYGB (n = 681) or AGB (n = 555). Liver biopsy samples were available for 1201 patients (97.2% of those at risk) at baseline, 578 patients (47.2%) at 1 year, and 413 patients (68.9%) at 5 years. Results: At baseline, NAFLD was present in 86% patients and categorized as severe [NAFLD activity score (NAS) ≥3] in 22% patients. RYGB patients had a higher body mass index (49.8 ± 8.2 vs 46.8 ± 6.5 kg/m2, P < 0.001) and more severe NAFLD (NAS: 2.0 ± 1.5 vs 1.7 ± 1.4, P = 0.004) than AGB patients. Weight loss at 5 years was 25.5% ± 11.8% after RYGB versus 21.4% ± 12.7% after AGB (P < 0.001). When analyzed with a mixed model, all NAFLD parameters improved after surgery (P < 0.001) and improved significantly more after RYGB than after AGB [steatosis (%): 1 year, 7.9 ± 13.7 vs 17.9 ± 21.5, P < 0.001/5 years, 8.7 ± 7.1 vs 14.5 ± 20.8, P < 0.05; NAS: 1 year, 0.7 ± 1.0 vs 1.1 ± 1.2, P < 0.001/5 years, 0.7 ± 1.2 vs 1.0 ± 1.3, P < 0.05]. In multivariate analysis, the superiority of RYGB was primarily but not entirely explained by weight loss. Conclusions: The improvement of NAFLD was superior after RYGB than after AGB. We enrolled 1236 obese patients in a longitudinal study with sequential liver biopsies before and after gastric bypass [Roux-en-Y gastric bypass (RYGB)] or gastric banding [adjustable gastric banding (AGB)]. Nonalcoholic fatty liver disease improved from baseline to 5 years after both interventions but more significantly after RYGB than after AGB. In multivariate analysis, the superiority of RYGB was primarily but not entirely explained by weight loss.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AGB also improved steatosis (41.9%), although RYGB showed greater efficacy (76.2%) [119].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [119]
In the citing paper
“AGB also improved steatosis (41.9%), although RYGB showed greater efficacy (76.2%) [119].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [119]
In the citing paper
“AGB also improved steatosis (41.9%), although RYGB showed greater efficacy (76.2%) [119].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [119]
In the citing paper
“AGB showed modest NAS improvement (35.3%) [119].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [119]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits
De Vadder, F., Kovatcheva-Datchary, P., Goncalves, D., Vinera, J., Zitoun, C., Duchampt, A., Bäckhed, F., & Mithieux, G. (2014) · Cell · doi:10.1016/j.cell.2013.12.016 · Cited by 2,200
Sjöström, L. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12012 · Cited by 1,835
Chalasani, N., Younossi, Z. M., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K. J., Charlton, M., & Sanyal, A. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.001 · Cited by 1,805
Bland, J. M., & Altman, D. G. (1995) · BMJ · doi:10.1136/bmj.310.6977.446 · Cited by 1,036
(1992) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.2.615s · Cited by 748
Bile acid receptors as targets for drug development
Schaap, F. G., Trauner, M., & Jansen, P. L. M. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.151 · Cited by 696
Long-Term Outcomes After Bariatric Surgery
O’Brien, P. E., MacDonald, L., Anderson, M. L., Brennan, L., & Brown, W. A. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e31827b6c02 · Cited by 545
Caldwell, S. H., & Crespo, D. M. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.02.013 · Cited by 499
Cited by
Sorted by citations
Items 101–200 of 226
NAFLD in Cardiovascular Diseases: A Contributor or Comorbidity?
Chen, B. Y., Tang, W. H. W., Rodriguez, M., Corey, K. E., Sanyal, A. J., Kamath, P. S., Bozkurt, B., Virk, H. U. H., Pressman, G. S., Lazarus, J. V., et al. (2022) · Seminars in Liver Disease · doi:10.1055/s-0042-1757712 · Cited by 22
The Effect of Bariatric Surgery on the Spectrum of Fatty Liver Disease
Nostedt, J. J., Switzer, N. J., Gill, R. S., Dang, J. T., Birch, D. W., de Gara, C., Bailey, R. J., & Karmali, S. (2016) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2016/2059245 · Cited by 21
Liver Transplantation After Bariatric Surgery: a Clinical Cohort Study
Fipps, D. C., Goetze, R. E., Clark, M. M., Mara, K. C., Watt, K. D. S., Jowsey‐Gregoire, S. G., Heimbach, J. K., & Grothe, K. B. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05483-x · Cited by 20
Savari, F., & Mard, S. A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28468 · Cited by 21
NAFLD as the metabolic hallmark of obesity
Rojano‐Toimil, A., Sena, E., Manzano-Núñez, R., Pericàs, J. M., & Ciudin, A. (2022) · Internal and Emergency Medicine · doi:10.1007/s11739-022-03139-x · Cited by 22
Billeter, A. T., Herrera, J. R. D. L. G., Scheurlen, K. M., Nickel, F., Billmann, F. G., & Müller-Stich, B. P. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0009 · Cited by 19
Bariatric surgery, lipoprotein metabolism and cardiovascular risk
Tailleux, A., Rouskas, K., Pattou, F. N., & Staels, B. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000197 · Cited by 21
Self-citationCoq, B. L., Fréring, V., Ghunaim, M., Campan, P., Dabrowski, A., Mulliez, E., Loridan, E., Combemale, F., Denimal, F. A., Torres, F., et al. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001835 · Cited by 18
Self-citationPaccou, J., Thuillier, D., Courtalin, M., Pigny, P., Labreuche, J., Cortet, B., & Pattou, F. N. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.12.004 · Cited by 18
Self-citationNonalcoholic liver disease: Epidemiology, risk factors, natural history, and management strategies
Agyapong, G., Dashti, F., & Banini, B. A. (2023) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15012 · Cited by 18
Spivak, H., Munz, Y., Rubin, M., Raz, I., Shohat, T., & Blumenfeld, O. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.11.006 · Cited by 17
Motamedi, M. A. K., Rakhshani, N., Khalaj, A., & Barzin, M. (2017) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2017.07.062 · Cited by 16
Ledoux, S., Sami, O., Calabrese, D., Gall, M. L., Flamant, M., & Coupaye, M. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.10.035 · Cited by 16
Metabolism of testosterone during weight loss in men with obesity
Van de Velde, F., Deventer, K., Van Gansbeke, W., Van Eenoo, P., Van Renterghem, P., Fiers, T., Reyns, T., Kaufman, J. M., Van Nieuwenhove, Y., & Lapauw, B. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105851 · Cited by 17
Current Controversies in Metabolic Surgery for Nonalcoholic Fatty Liver Disease
Perysinakis, I., Pappis, H. C., & Margaris, E. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03705-x · Cited by 15
Salman, M. A., Salman, A., Omar, H. S. E., Abdelsalam, A., Mostafa, M. S., Tourky, M. S., Sultan, A. A. E. A., Elshafey, M. H., Abdelaty, W. R., Salem, A., et al. (2020) · Surgical Endoscopy · doi:10.1007/s00464-020-07725-y · Cited by 15
BYPASS VS. SLEEVE AND ITS EFFECTS IN NON-ALCOHOLIC FATTY LIVER DISEASE: WHAT IS THE BEST TECHNIQUE?
Goldoni, M. B., Fontes, P. R. O., Guimarães, M. M., Neto, J. A. D., NOGUEIRA, T., Teixeira, U. F., Giacomazzi, C. B., Kiss, G., Pioner, S. R., & Rodrigues, P. D. (2020) · ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) · doi:10.1590/0102-672020200003e1549 · Cited by 15
Gonzalez, J., Ouazzani, S., Monino, L., Beyer‐Berjot, L., Berdah, S. V., Cauche, N., Delattre, C., Peetermans, J. A., Dayton, P., Gjata, O., et al. (2022) · Scientific Reports · doi:10.1038/s41598-021-02921-9 · Cited by 15
Caiazzo, R. J., Bauvin, P., Marciniak, C., Saux, P., Geoffrey, J. M., Arnoux, R., Benchetrit, S., Dargent, J., Chevallier, J., Fréring, V., et al. (2023) · Annals of Surgery · doi:10.1097/sla.0000000000005969 · Cited by 15
Self-citationSsentongo, P., Ssentongo, A. E., Dykes, T. M., Pauli, E. M., & Soybel, D. I. (2018) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2018.07.655 · Cited by 15
Therapeutic approaches for non-alcoholic steatohepatitis
Gaal, L. F. V., Mertens, J., Francque, S., & Block, C. E. M. D. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188211034300 · Cited by 15
Regulation of Energy Homeostasis After Gastric Bypass Surgery
Yarmush, M. L., D'Alessandro, M. R., & Saeidi, N. (2017) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-105140 · Cited by 14
Nonmedicinal Interventions in Nonalcoholic Fatty Liver Disease
Neuman, M. G., Nanau, R. M., & Cohen, L. B. (2015) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2015/273595 · Cited by 14
Azulai, S., Grinbaum, R., Beglaibter, N., Eldar, S. M., Rubin, M., Ben-Haroush Schyr, R., Romano-Zelekha, O., & Ben-Zvi, D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10051144 · Cited by 13
Grocic, M., Nguyen, M., & Sanyal, A. J. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70662 · Cited by 16
Fu, C., Zhou, Y. J., Wu, Z., Li, Y., Zhou, W., & Wang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.611213 · Cited by 13
Sleeve gastrectomy causes weight‐loss independent improvements in hepatic steatosis
McGlone, E. R., Siebert, M., Dore, M. H., Hope, D. C. D., Davies, I., Owen, B. M., Khoo, B. C. E., Goldin, R. D., Carling, D., Bloom, S. R., et al. (2023) · Liver International · doi:10.1111/liv.15614 · Cited by 12
Weight Loss for a Healthy Liver
Marchesini, G., Mazzella, N., & Forlani, G. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.015 · Cited by 13
Tasabehji, D., Saleh, S., & Mokadem, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14124012 · Cited by 14
Murakami, E., Nakahara, T., Hiramatsu, A., Morio, K., Fujino, H., Yamauchi, M., Kawaoka, T., Tsuge, M., Imamura, M., Aikata, H., et al. (2021) · Medicine · doi:10.1097/md.0000000000026436 · Cited by 12
Jamialahmadi, T., Jangjoo, A., Rezvani, R., Goshayeshi, L., Tasbandi, A., Nooghabi, M. J., Rajabzadeh, F., Ghaffarzadegan, K., Mishamandani, Z. J., & Nematy, M. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04452-0 · Cited by 12
Corbière, L., Scanff, A., Desfourneaux, V., Merdrignac, A., Ingels, A., Thibault, R., Bouguen, G., & Bergeat, D. (2022) · British journal of surgery · doi:10.1093/bjs/znac398 · Cited by 12
Li, M., Cao, D., Liu, Y., Jin, L., Zeng, N., Wang, L., Zhao, K., Lv, H., Zhang, M., Zhang, P., et al. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04415-5 · Cited by 12
Effects of anti-diabetic treatments in type 2 diabetes and fatty liver disease
Lamos, E. M., Kristan, M. M., Siamashvili, M., & Davis, S. N. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1917374 · Cited by 12
Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Facts and Hopes
Adinolfi, L. E., Marrone, A., Izzi, A., & Craxì, A. (2025) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2025.103411 · Cited by 11
Treatment of NASH with Gastric Bypass
Jirapinyo, P., & Thompson, C. C. (2018) · Current Gastroenterology Reports · doi:10.1007/s11894-018-0653-6 · Cited by 11
Bariatric surgery and non-alcoholic fatty liver disease
Julià, H., Benaiges, D., & Pedro‐Botet, J. (2022) · Medicina Clínica · doi:10.1016/j.medcli.2021.12.003 · Cited by 11
Advances in obesity pharmacotherapy; learning from metabolic surgery and beyond
Tsilingiris, D., & Kokkinos, A. D. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155741 · Cited by 13
Lim, J., Park, H. S., Lee, S. K., Jang, Y. J., Lee, Y. J., & Heo, Y. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1808-2 · Cited by 10
Stanley, C., Mallik, R., Hamid, N., Jassil, F. C., Reuven, V., Ruwona, T., Dicken, S. J., Qamar, S., Norton, B. C., Kingett, H., et al. (2026) · Nature Medicine · doi:10.1038/s41591-026-04416-4 · Cited by 10
The Role Bariatric Surgery and Endobariatric Therapies in Nonalcoholic Steatohepatitis
Yeoh, A. J., Wong, R. J., & Singal, A. K. (2023) · Clinics in Liver Disease · doi:10.1016/j.cld.2023.01.009 · Cited by 10
Ma, N., Ma, R., Tang, K., Li, X., & He, B. (2020) · Journal of Diabetes Research · doi:10.1155/2020/4326549 · Cited by 10
Goday, A., Julià, H., de Vargas‐Machuca, A., Pedro‐Botet, J., Benavente, S., Ramón, J. M., Pera, M., Casajoana, A., Villatoro, M., Fontané, L., et al. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.07.021 · Cited by 10
Lim, W. H., Lin, S. Y., Ng, C. H., Tan, D. J. H., Xiao, J., Yong, J. N., Tay, P. W. L., Syn, N. L. X., Chin, Y. H., Chan, K. E., et al. (2022) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-21-520 · Cited by 10
Rêgo, A. D. S., Zulin, A., SCOLARI, S., Marcon, S. S., & Radovanovic, C. A. T. (2017) · Revista do Colégio Brasileiro de Cirurgiões · doi:10.1590/0100-69912017002011 · Cited by 9
Canivet, C. M., Perney, P., Cherick, F., Orlowski, M., Patouraux, S., Bailly‐Maitre, B., Tran, A., Iannelli, A., Gual, P., & Anty, R. (2020) · JGH Open · doi:10.1002/jgh3.12309 · Cited by 9
RYGB increases postprandial gastric nesfatin-1 and rapid relieves NAFLD via gastric nerve detachment
Wang, G., Wang, Q., Bai, J., Li, G., Tao, K., Wang, G., & Xia, Z. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243640 · Cited by 9
Juárez-Hernández, E., Velázquez-Alemán, A. P., Castro‐Narro, G., Uribe, M., & López-Méndez, I. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1026444 · Cited by 9
Reversing Advanced Hepatic Fibrosis in NASH: Clearly Possible, but Widely at Hand?
Caldwell, S. H., & Argo, C. K. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3540-0 · Cited by 9
Pan, Q., Qin, T., Gao, Y., Li, S., Li, D., Peng, M., Zhai, H., & Xu, G. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.12.014 · Cited by 9
Marciniak, C., Lenne, X., Bruandet, A., Hamroun, A., Génin, M., Baud, G., THEIS, D., Pattou, F. N., & Caiazzo, R. J. (2023) · Annals of Surgery · doi:10.1097/sla.0000000000006039 · Cited by 8
Self-citationBrea, Á., Pintó, X., Ascaso, J. F., Blasco, M., Rodríguez, Á. D., González‐Santos, P., Hernández‐Mijares, A., Mantilla, T., Millán, J., & Pedro‐Botet, J. (2016) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2016.06.002 · Cited by 8
Guveli, H., Ozlu, T., Tasar, B. E., Kenger, E. B., & Eda, K. (2021) · Hepatology Forum · doi:10.14744/hf.2021.2021.0014 · Cited by 3
Chen, S., Tang, L., Guillot, A., & Liu, H. (2022) · Metabolites · doi:10.3390/metabo13010011 · Cited by 8
The Role of Metabolic Surgery in Non-alcoholic Steatohepatitis Improvement
Caravatto, P. P. D. P., & COHEN, R. V. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0681-y · Cited by 8
Guggino, J., Tamisier, R., Betry, C., Coumes, S., Arvieux, C. C., Wion, N., Reche, F., Pépin, J., & Borel, A. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00903-5 · Cited by 7
Future of bariatric surgery beyond simple weight loss: Metabolic surgery
Caiazzo, R. J., Marciniak, C., Rémond, A., Baud, G., & Pattou, F. N. (2023) · Journal of Visceral Surgery · doi:10.1016/j.jviscsurg.2023.01.005 · Cited by 11
Self-citationChetboun, M., Masset, C., Maanaoui, M., Defrance, F., Gmyr, V., Raverdy, V., Hübert, T., Bonner, C., Supiot, L., Kerleau, C., et al. (2023) · Transplant International · doi:10.3389/ti.2023.11950 · Cited by 8
Self-citationAzulai, S., Grinbaum, R., Beglaibter, N., Eldar, S. M., Rubin, M., Carmi, S., Schyr, R. B., Romano‐Zelekha, O., & Ben‐Zvi, D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122724 · Cited by 9
Duodenal mucosal resurfacing with photodynamic therapy using methylene blue in a mouse model
Yang, S. M., Myeong, S., Yun, S. K., Kwak, M. H., Cho, Y. K., Choi, M., & Park, J. M. (2023) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2023.103733 · Cited by 7
Giraudi, P. J., Giuricin, M., Bonazza, D., de Manzini, N., Tiribelli, C., Palmisano, S., & Rosso, N. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-00687-0 · Cited by 6
Brea, Á., Pintó, X., Ascaso, J. F., Blasco, M., Díaz, Á., González‐Santos, P., Hernández‐Mijares, A., Mantilla, T., Millán, J., & Pedro‐Botet, J. (2017) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2017.07.001 · Cited by 6
Roux-en-Y Gastric Bypass Reversal for Severe Malnutrition and Cirrhosis
Beghdadi, N., Soprani, A., Kraemer, A., Bucur, P. O., Barrat, C., & Genser, L. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03770-2 · Cited by 6
Tarasco, E., Boyle, C. N., Pellegrini, G., Arnold, M., Steiner, R., Hornemann, T., Nasias, D., Kardassis, D., Whiting, L., & Lutz, T. A. (2019) · International Journal of Obesity · doi:10.1038/s41366-019-0408-y · Cited by 7
Bettini, S., Bordigato, E., Milan, G., Prà, C. D., Favaretto, F., Belligoli, A., Sanna, M., Serra, R., D, M. F. M., Prevedello, L., et al. (2019) · Obesity Facts · doi:10.1159/000499717 · Cited by 6
Pros and cons of Roux en-Y gastric bypass surgery in obese patients with type 2 diabetes
Justinussen, T., Madsbad, S., Holst, J. J., & Bojsen-Møller, K. N. (2019) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2019.1628639 · Cited by 6
Role of duodenal mucosal resurfacing in controlling diabetes in rats
Nie, L., Cheng, Z., He, Y., Yan, Q.-H., Sun, Y., Yang, X., Tian, J., Zhu, P.-F., Yu, J., Zhou, H., et al. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i3.102277 · Cited by 6
The Challenging Ethical Landscape of Non-alcoholic Fatty Liver Disease
Berry, P., & Kotha, S. (2022) · EMJ Hepatology · doi:10.33590/emjhepatol/21-00217 · Cited by 5
Courtalin, M., Verkindt, H., Daoud, N. O., Ramdane, N., Cortet, B., Pattou, F. N., & Paccou, J. (2023) · Nutrients · doi:10.3390/nu15041007 · Cited by 5
Self-citationTan, C.-H., Al-Kalifah, N., Lee, W., Ser, K., Lee, Y.-C., & Chen, J. (2018) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2018.04.010 · Cited by 5
On Behalf of the LAGB10 Group, Pontiroli, A. E., Zakaria, A. S., Micheletto, G., Osio, C., Saibene, A., & Folli, F. B. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1221-0 · Cited by 5
Targeting metabolism in the management of PCOS: Metformin and beyond
Oğuz, S. H., Şendur, S. N., Ünlütürk, U., & Yıldız, B. O. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823045-9.00006-7 · Cited by 5
Decision Tree for the Performance of Intraoperative Liver Biopsy During Bariatric Surgery
Barbois, S., Stürm, N., Aron‐Wisnewsky, J., Clément, K., Bédossa, P., Genser, L., Hilleret, M., Costentin, C. E., Reche, F., Arvieux, C. C., et al. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05309-w · Cited by 4
Norouzian Ostad, A., Rajabzadeh, F., Jamialahmadi, T., Goshayeshi, L., Ranjbar, G., Rezvani, R., Nematy, M., & Jangjoo, A. (2023) · Updates in Surgery · doi:10.1007/s13304-022-01421-3 · Cited by 4
Meta-analysis of genome-wide DNA methylation and integrative OMICs in human skeletal musclePreprint
Voisin, S. A. C., Jacques, M., Landen, S., Harvey, N. R., Haupt, L. M., Griffiths, L. R., Gancheva, S., Ouni, M., Jähnert, M., Ashton, K. J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.28.315838 · Cited by 4
Self-citationLongsomboon, R., Kachornvitaya, P., Prasoppokakorn, T., Treeprasertsuk, S., Boonchaya‐anant, P., Klaikaew, N., & Udomsawaengsup, S. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04482-x · Cited by 3
Nonalcoholic Fatty Liver Disease
de Holanda, N. C. P., Oliveira, A. R. L., Carvalho, N., & Souza, B. L. (2022) · Springer eBooks · doi:10.1007/978-3-030-90684-9_42 · Cited by 3
Associations between Pre-Bariatric High-Sensitivity C-Reactive Protein and Post-Surgery Outcomes
Jamialahmadi, T., Nematy, M., Bo, S., Ponzo, V., Jangjoo, A., Goshayeshi, L., Tasbandi, A., Nikiforov, N. G., & Sahebkar, A. (2021) · Diagnostics · doi:10.3390/diagnostics11040721 · Cited by 3
Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease
Jukić, L. V. (2021) · Acta Clinica Croatica · doi:10.20471/acc.2021.60.s1.03 · Cited by 3
Effects of bariatric surgery on bone metabolism: focusing on vitamin D
Avdeeva, V. A., Suplotova, L. A., & Rozhinskaya, L. Y. (2022) · Obesity and metabolism · doi:10.14341/omet12702 · Cited by 6
Goutchtat, R., Quenon, A., Clarisse, M., Delalleau, N., Coddeville, A., Gobert, M., Gmyr, V., Kerr-Conte, J. A., Pattou, F. N., & Hübert, T. (2023) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.425 · Cited by 3
Self-citationFasting, Nutrition and Weight Loss: An Approach to Refine Non-Alcoholic Fatty Liver Disease
Al-Samhari, G. A., Al-Mushiki, G. M., Tamrakar, R., ABDULLAHI, G., Lin, Y.-D., & Tang, X. (2021) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.67.366 · Cited by 4
HSUEH, W. H., Shope, T. R., Koch, T. R., & Smith, C. I. (2016) · Journal of Gastroenterology and Hepatology Research · doi:10.17554/j.issn.2224-3992.2016.05.564 · Cited by 3
Boudaoud, A. A., Rives‐Lange, C., Perregaux, J.-F., Radu, A., Messager, D., Barsamian, C., Carette, C., & Czernichow, S. (2019) · La Presse Médicale · doi:10.1016/j.lpm.2019.10.026 · Cited by 2
Ichikawa, H., Imoto, H., Tanaka, N., Fujishima, F., Tsuchiya, T., Watanabe, K., Aoki, T., Kohyama, A., Morikawa, T., Ohnuma, S., et al. (2021) · Surgery · doi:10.1016/j.surg.2021.07.003 · Cited by 2
Advances in metformin for the treatment of non-alcoholic fatty liver disease in children
Wu, Q., Zeng, S., Peng, J., Yuan, Y., Zhu, Z., Xie, Z., Huang, Z., Huang, J.-S., Lai, J., Chen, J.-A., et al. (2022) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2022.2118112 · Cited by 2
Baffoe, S. K. A., Rohrer, J. E., & Goes, J. (2018) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.13068 · Cited by 2
Bariatric surgery for nonalcoholic fatty liver disease in adolescents with severe obesity
Campos, G. M., & Lanning, D. A. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.12.015 · Cited by 2
Wang, Y., Chen, J., Chen, Y., & Wu, X. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.10.030 · Cited by 2
Lassailly, G., Caiazzo, R. J., Mathurin, P., & Pattou, F. N. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.11.035 · Cited by 2
Self-citationPLAKIDA, A. L., Юшковська, О., & Sierpińska, L. E. (2026) · World Journal of Hepatology · doi:10.4254/wjh.v18.i3.113284 · Cited by 1
Evidence-based management of non-alcoholic fatty liver disease
Kodisinghe, S. K., & Niriella, M. A. (2015) · Sri Lanka Journal of Diabetes Endocrinology and Metabolism · doi:10.4038/sjdem.v5i1.7270 · Cited by 1
The Role of Bariatric Surgery in Fatty Liver
Geerts, A. M., & Lefere, S. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96975 · Cited by 1
Adult Non-alcoholic Fatty Liver Disease (NAFLD)
Pedersen, J. S., & Bendtsen, F. (2018) · Springer eBooks · doi:10.1007/978-3-319-98890-0_2 · Cited by 1
Billeter, A. T., & Müller-Stich, B. P. (2019) · Der Chirurg · doi:10.1007/s00104-018-0786-z · Cited by 1
Avenir de la chirurgie bariatrique au-delà de la surcharge pondérale : la chirurgie métabolique
Caiazzo, R. J., Marciniak, C., Rémond, A., Baud, G., & Pattou, F. N. (2023) · Journal de Chirurgie Viscérale · doi:10.1016/j.jchirv.2023.01.002 · Cited by 1
Self-citationStaufer, K., Eilenberg, M., & Prager, G. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3566-4 · Cited by 1
Hodson, K. K. (2019) · Cited by 1
Revue de presse / Press review
Blanchard, C. L., Sterkers, A., & Genser, L. (2020) · Obésité · doi:10.3166/obe-2020-0091
Current and Emerging Therapies for Nonalcoholic Fatty Liver Disease
Gawrieh, S., & Chalasani, N. (2015) · Springer eBooks · doi:10.1007/978-3-319-20538-0_16
Metadata
- Authors
- Caiazzo, R., Lassailly, G., Leteurtre, E., Baud, G., Verkindt, H., Raverdy, V., Buob, D., Pigeyre, M., Mathurin, P., & Pattou, F.
- Affiliations
- Inserm (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- Corresponding author
- Caiazzo, Robert
- Verkindt, Hélène
- Raverdy, Violeta
- Pattou, François
- ORCID
- Venue
- Annals of Surgery
- Published
- 2014-11
- Volume
- 260
- Issue
- 5
- Pages
- 893-899
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2332106446
- Cited by
- 226
- References
- 21
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 11 · 2023: 15 · 2022: 25 · 2021: 31 · 2020: 27 · 2019: 24 · 2018: 22 · 2017: 20 · 2016: 18 · 2015: 20 · 2014: 1
- FWCI
- 19.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Surgery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Minimally Invasive Surgical Techniques
- Keywords
- Roux-en-Y gastric bypass, gastric banding, non-alcoholic fatty liver disease, bariatric surgery, morbid obesity, liver histopathology, NAFLD activity score, hepatic steatosis, liver fibrosis, weight loss, long-term outcomes, liver biopsy histology, NAFLD progression
- MeSH terms
- Biopsy, Female, Humans, Longitudinal Studies, Male, Middle Aged, Obesity, Morbid, Prospective Studies, Gastric Bypass, Gastroplasty, Body Mass Index, Treatment Outcome, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review